We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biovail Sues Andrx Over Planned Cardizem Generic

Law360 (August 16, 2005, 12:00 AM EDT) -- A popular drug for controlling blood pressure is at the center of a new patent lawsuit brought by Biovail Laboratories against generics maker Andrx Pharmaceuticals.

Biovail, based in Barbados, sued Florida-based Andrx in Delaware district court. It asserted a patent that reshaped the hypertension drug niche in the mid-1990s.

Andrx completed an Abbreviated New Drug Application with the Food and Drug Administration, stating its intentions to create and market a generic version of Biovail’s Cardizem LA. Compelled by the Hatch-Waxman Act, Andrx informed Biovail of its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.